Artificial Protein Catalyst for In Vivo Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing catalysts used in in vivo synthetic chemical treatments are quickly inactivated by in vivo substances such as thiol-containing glutathione, limiting their effectiveness and stability within biological systems.

Innovation Solution

A novel artificial protein catalyst is developed by incorporating a metal catalyst, such as ruthenium, into the hydrophobic binding pocket of human serum albumin (HSA), protecting it from in vivo substances and maintaining catalytic activity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If metal catalysts are used in in vivo synthetic chemical treatments, then catalytic activity is achieved, but the catalyst is quickly inactivated by thiol-containing glutathione and other in vivo substances

Engineering Contradiction:
Improvecatalyst stabilityVSAvoidinactivation by glutathione
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The metal catalyst is nested within the hydrophobic binding pocket of human serum albumin, creating a protective environment that shields the catalyst from in vivo substances while maintaining catalytic function. The catalyst is effectively housed inside a biological carrier that provides steric protection.

Inventive Principle:
Principle #7Nested doll (Nesting)

Solution Approach 2:

Human serum albumin acts as an intermediary between the metal catalyst and the in vivo environment. The protein mediates the interaction by providing a hydrophobic pocket that accommodates the catalyst while isolating it from harmful thiol-containing substances like glutathione in the surrounding aqueous environment.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If metal catalysts are exposed to hydrophilic environment, then catalyst is accessible for reactions, but catalyst activity is quickly lost due to interaction with in vivo substances

Engineering Contradiction:
Improvecatalytic activityVSAvoidcatalyst lifespan
Core Design Contradiction:
ProductivityVSDuration of action of moving object

Solution Approach 1:

The invention creates a local hydrophobic environment within the hydrophobic binding pocket of human serum albumin, contrasting with the global hydrophilic environment of the cytoplasm or blood plasma. This local quality change allows the metal catalyst to maintain activity by being surrounded by hydrophobic residues that prevent interaction with harmful hydrophilic in vivo substances.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The hydrophobic binding pocket of human serum albumin creates an inert-like environment for the metal catalyst, protecting it from reactive thiol-containing substances. The hydrophobic pocket acts as a protective atmosphere that isolates the catalyst from the reactive hydrophilic environment outside, extending its functional lifespan.

Inventive Principle:
Principle #39Inert atmosphere (Inert environment)

3Reliability

If catalyst is protected from in vivo substances, then catalyst stability is improved, but accessibility to substrate may be reduced

Engineering Contradiction:
Improvecatalyst stabilityVSAvoidsubstrate accessibility
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

Human serum albumin serves multiple functions: it protects the metal catalyst from inactivation while simultaneously allowing substrate access through its binding pocket. The protein structure is designed to accommodate both protection and accessibility requirements, making the system multi-functional rather than requiring separate protective and catalytic components.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The artificial protein catalyst effectively protects the metal catalyst from inactivation by in vivo substances, maintaining its catalytic activity and potential therapeutic applications within the body.

Implementation Method 1

accommodates a metal catalyst in the hydrophobic binding pocket of HSA

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Data Source

PatentUS12269021B2Artificial protein catalyst
Publication Date: 2025.04.08 GLYTECH LLC
  • US12269021B2 patent drawing
  • US12269021B2 patent drawing
  • US12269021B2 patent drawing

AI summary

[Problem] To provide a novel artificial protein catalyst that enables the protection of a catalyst from substances in vivo and has potential usefulness in therapeutic in vivo synthetic chemistry.[Solution] Provided is a complex of a protein and a catalyst selected from a metal catalyst or organic catalyst. In the complex according to the present invention, the protein is a protein having a hydrophobic pocket in the three-dimensional structure thereof, and the catalyst is housed in the hydrophobic pocket so that the catalyst is not or substantially not exposed to a hydrophilic environment.